Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
precore/core protein|Core and e antigen|Polymerase|
Integrated sequence
TGTCTTTCGGAGTGTGGATTCGCACTCCTCCAGCTTATAGACCACCAAATGCCCCTATCCTATCAACACTTCCGGAGACTACTGTTGTTAGACGACGAGG| |CAGGTCCCCTAGAAGAAGAACTCCCTCGCCTCGCAGACGAAGGTCTCAATCGCCGCGTCGCAGAAGATCTCAATCTCGGGAATCTCAATGTTAGTATTCC
End
59118901/58607534 (Hg38)
Nearest miRNA
hsa-let-7e/Upstream/57158;
Upstream sequence
gttcagcacagacctggggggttagggttaggggtgccgttggggttggggttggggttagggttaggggttagggttagggttagggtttagggttagg
Downstream sequence
gtttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttNNNNNNNNNNNNNNNNNN
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.